You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股异动|金斯瑞生物科技高开逾4%与杨森的合作达成重大里程碑
格隆汇 07-29 09:24
格隆汇7月29日丨金斯瑞生物科技(01548.HK)高开逾4%,报18.44港元,成交307万港元,总市值343亿港元。金斯瑞生物科技今日早间公布,公司于2017年12月22日发布的内幕消息公告,其内容有关(i)公司的非全资子公司美国传奇生物科技有限公司,(ii)公司的非全资子公司爱尔兰传奇生物科技有限公司及(iii)杨森生物科技有限公司签署了一项合作及许可协议,及(b)公司日期为2018年12月17日的内幕消息公告,其内容有关达成美国临床试验的第一个里程碑事件及传奇有权享有杨森应付的2500万美元的里程碑付款。公告称,根据协议条款及条件,有关美国临床试验的第二个及第三个里程碑事件已经达成,传奇有权就第二个及第三个里程碑享有由杨森向传奇分别支付的3000万美元及2500万美元的里程碑付款。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account